Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	0,00 %	0,00 %	10,20 %

Company Profile for BioPlus Acquisition Corp. Share

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Company Data

Name BioPlus Acquisition Corp.

Company BioPlus Acquisition Corp.

Symbol BIOS

Website https://bioplusspac.com

Primary Exchange

NASDAQ

ISIN KYG112171171

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Mr. R. Ross Haghighat

Market Capitalization 209 Mio

Country United States of America

Currency USD

Employees -

Address 260 Madison Avenue, 10026 New York

IPO Date 2022-01-28

Ticker Symbols

Name	Symbol
NASDAQ	BIOS

More Shares

Investors who BioPlus Acquisition Corp. hold also have the following shares in their portfolio:

Compass Therapeutics, Inc. - Common Stock Share

DZ BANK IS.C227 20/26 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog